title: Topical oxygen wound therapies for chronic wounds: a review.
abstract: Chronic wounds are an increasing problem in our ageing population and can arise in many different ways. Over the past decades it has become evident that sufficient oxygen supply is an essential factor of appropriate wound healing. Sustained oxygen deficit has a detrimental impact on wound healing, especially for patients with chronic wounds. This has been proven for wounds associated with peripheral arterial occlusive disease (PAOD) and diabetic foot ulcers (particularly in combination with PAOD). However, this is still under debate for other primary diseases. In the past few years several different new therapeutic approaches for topical oxygen therapies have been developed to support wound healing. These tend to fall into one of four categories: (1) delivery of pure oxygen either under pressurised or (2) ambient condition, (3) chemical release of oxygen via an enzymatic reaction or (4) increase of oxygen by facilitated diffusion using oxygen binding and releasing molecules. In this review article, the available therapeutic topical oxygen-delivering approaches and their impact on wound healing are presented and critically discussed. A summary of clinical data, daily treatment recommendations and practicability is provided.
  
  
  BACKGROUND
  J. Dissemond received an honorarium for lectures, advisory boards and/or clinical studies from the following companies: 3M, B. Braun, BSN, Coloplast, Convatec, Draco, Hartmann, KCI, Lohmann&Rauscher, Medoderm, Merz, Sastomed, Systagenix, UCB-Pharma, Urgo. K. Kröger received an honorarium for lectures, advisory boards and/or clinical studies from the following companies: Bayer, Sanofi, GSK, Hartmann, Sastomed, UCB-Pharma, Urgo. M. Storck received an honorarium for lectures for the following companies: KCI, Systagenix, and UCB-Pharma. A. Risse received an honorarium for lectures, advisory boards and/or clinical studies from the following companies: Bracco, Coloplast, Draco, Lilly Deutschland, NovoNordisk, Sastomed, Urgo. P. Engels received an honorarium for lectures, and consulting from the following companies: Sastomed, Oculus.
authors: Professor, Department for Dermatology, Venerology and Allergology, University School of Medicine, Essen, Germany.
authors: J
authors: J
authors: Dissemond
authors: K
authors: K
authors: Kröger
authors: M
authors: M
authors: Storck
authors: A
authors: A
authors: Risse
authors: P
authors: P
authors: Engels
mesh_terms: D017719:Diabetic Foot / Q000628:therapy; D006801:Humans; D006931:Hyperbaric Oxygenation; D007871:Leg Ulcer / Q000628:therapy*; D010100:Oxygen / Q000008:administration & dosage*; D003668:Pressure Ulcer / Q000628:therapy
chemical_list: D010100:Oxygen
keywords: chronic wound; diabetic foot ulcer; haemoglobin; hypoxia, oxygen; leg ulcer; wound healing